Find, compare & contact
Bucillamine
API Manufacturers & Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Bucillamine API 65002-17-7?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Bucillamine. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Bucillamine
- Synonyms:
- Bucilamina , Bucillaminum
- Cas Number:
- 65002-17-7
- DrugBank number:
- DB12160
- Unique Ingredient Identifier:
- R80LRA5WTF
General Description:
Bucillamine, identified by CAS number 65002-17-7, is a notable compound with significant therapeutic applications. Bucillamine has been used in trials studying the treatment and prevention of Gout and Rheumatoid Arthritis.
Classification:
Bucillamine belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom, classified under the direct parent group N-acyl-L-alpha-amino acids. This compound is a part of the Organic compounds, falling under the Organic acids and derivatives superclass, and categorized within the Carboxylic acids and derivatives class, specifically within the Amino acids, peptides, and analogues subclass.
Categories:
Bucillamine is categorized under the following therapeutic classes: Amino Acids, Amino Acids, Neutral, Amino Acids, Peptides, and Proteins, Amino Acids, Sulfur, Analgesics, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Antiinflammatory and Antirheumatic Products, Antioxidants, Antirheumatic Agents, Biological Factors, Compounds used in a research, industrial, or household setting, Musculo-Skeletal System, Penicillamine and Similar Agents, Peripheral Nervous System Agents, Protective Agents, Sensory System Agents, Specific Antirheumatic Agents, Sulfhydryl Compounds, Sulfur Compounds. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Bucillamine is a type of Anti-inflammatory Agents
Anti-inflammatory agents are a crucial category of pharmaceutical active pharmaceutical ingredients (APIs) used to treat various inflammatory conditions. These agents play a vital role in alleviating pain, reducing swelling, and controlling inflammation in the body. They are widely employed in the management of diverse medical conditions, including arthritis, autoimmune disorders, asthma, and skin conditions like dermatitis.
Anti-inflammatory APIs primarily function by inhibiting the production of specific enzymes called cyclooxygenases (COX) and lipoxygenases (LOX). These enzymes are responsible for the synthesis of pro-inflammatory molecules known as prostaglandins and leukotrienes, respectively. By suppressing the activity of COX and LOX, anti-inflammatory agents effectively curtail the production of these inflammatory mediators, thereby mitigating inflammation.
Common examples of anti-inflammatory APIs include non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, aspirin, and naproxen. These agents exhibit analgesic, antipyretic, and anti-inflammatory properties. Another group of anti-inflammatory APIs includes corticosteroids, such as prednisone and dexamethasone, which are synthetic hormones that modulate the body's immune response to control inflammation.
In conclusion, anti-inflammatory agents are a vital category of pharmaceutical APIs widely used to manage inflammation-related disorders. They target enzymes involved in the synthesis of pro-inflammatory molecules, effectively reducing pain and swelling. NSAIDs and corticosteroids are commonly prescribed anti-inflammatory APIs due to their efficacy in controlling inflammation.
